Pharmabiz
 

Nicholas Piramal launches hypertension product 'RESPeRATE'

Our Bureau, MumbaiThursday, February 7, 2008, 08:00 Hrs  [IST]

Nicholas Piramal India Limited (NPIL), a leading pharmaceutical company, has launched hypertension product 'RESPeRATE' in the domestic market. RESPeRATE is a patented product, developed on the yogic principles of pranayama. RESPeRATE is a portable electronic device that helps lower blood pressure naturally by enabling the patient to quickly harness the power of paced breathing. Scientific evidence has shown that paced breathing, if done effortlessly, can lower blood pressure significantly by relaxing the muscles surrounding constricted blood vessels. It is the only medical device for high blood pressure treatment using patented Interactive Respiratory Pacing technology. It offers effective, non-drug approach to lowering high blood pressure, 14/8 mm Hg average BP reduction within 8 weeks, no side effects, no drug interactions, pleasant to use and well supported with clinical trials. Speaking at the launch Dr Swati Piramal, director strategic alliances and communications, NPIL, said, "RESPeRATE is a perfect fit within our health solutions portfolio. It complements our existing pharmacy product offerings, and we look forward to bringing our expertise to this innovative solution for hypertension in India. Considerable effort is needed to prevent and reduce the increasingly large burden of hypertension in India". "This is great news for the millions of hypertension sufferers in India who seek a new option to help control their condition. Traditional treatment methods of diet, exercise and medication are often unable to help patients reach their lower blood pressure goals. Left untreated high blood pressure may lead to heart attack, stroke and kidney or heart failure," said Dr Hiremath, HoD, department of cardiology, Poona Hospital & Research Center. RESPeRATE is manufactured by Intercure Ltd an Israeli company. It is FDA-cleared for over-the-counter sale. The each unit of this product is valued at Rs 13,300. In a six months time, company is targeting to achieve 2000 sales of the same products. It will be mostly available in the heart clinics, institute and many other places. It is multi people use products, which doesn't require any manual service.

 
[Close]